A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody‐antigen system

Hepatocellular carcinoma (HCC) is a malignancy with a dismal survival rate. The novel autoantibodies panel may provide new insights for the diagnosis of HCC. Biomarkers screened by two methods (bioinformatics and the antigen‐antibody system) were taken as candidate tumor‐associated antigens (TAAs)....

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jinyu, Wang, Peng, Han, Zhuo, Li, Tiandong, Yi, Chuncheng, Qiu, Cuipeng, Yang, Qian, Sun, Guiying, Dai, Liping, Shi, Jianxiang, Wang, Keyan, Ye, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819288/
https://www.ncbi.nlm.nih.gov/pubmed/34821436
http://dx.doi.org/10.1111/cas.15217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819288/
https://www.ncbi.nlm.nih.gov/pubmed/34821436
http://dx.doi.org/10.1111/cas.15217

Ejemplares similares